Yiannis Ioannou
Overview
Explore the profile of Yiannis Ioannou including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
71
Citations
1428
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ioannou Y, Beukelman T, Murray M, Erkan D
Eur J Rheumatol
. 2023 Mar;
10(1):39-44.
PMID: 36880810
Antiphospholipid syndrome is a systemic autoimmune disorder characterized by vascular thrombosis and/or obstetric events in association with persistently elevated antiphospholipid antibodies. Antiphospholipid syndrome is typically considered a rare disease, but...
2.
Robinson G, Waddington K, Coelewij L, Peng J, Naja M, Wincup C, et al.
EBioMedicine
. 2021 Feb;
65:103243.
PMID: 33640328
Background: Cardiovascular disease is a leading cause of mortality in patients with juvenile-onset systemic lupus erythematosus (JSLE). Traditional factors for cardiovascular risk (CVR) prediction are less robust in younger patients....
3.
Barturen G, Babaei S, Catala-Moll F, Martinez-Bueno M, Makowska Z, Martorell-Marugan J, et al.
Arthritis Rheumatol
. 2021 Jan;
73(6):1073-1085.
PMID: 33497037
Objective: Clinical heterogeneity, a hallmark of systemic autoimmune diseases, impedes early diagnosis and effective treatment, issues that may be addressed if patients could be classified into groups defined by molecular...
4.
Robinson G, Peng J, Donnes P, Coelewij L, Naja M, Radziszewska A, et al.
Lancet Rheumatol
. 2020 Aug;
2(8):e485-e496.
PMID: 32818204
Background: Juvenile-onset systemic lupus erythematosus (SLE) is a rare autoimmune rheumatic disease characterised by more severe disease manifestations, earlier damage accrual, and higher mortality than in adult-onset SLE. We aimed...
5.
Wilkinson M, Radziszewska A, Wincup C, Ioannou Y, Isenberg D, Manson J, et al.
Rheumatology (Oxford)
. 2019 Jul;
59(1):194-204.
PMID: 31292651
Objective: The inflammatory idiopathic myopathies (IIM) are a group of rare autoimmune diseases defined by muscle weakness and characterized by pro-inflammatory infiltrates in muscle. Little is known about the immunological...
6.
Hanns L, Radziszewska A, Suffield L, Josephs F, Chaplin H, Peckham H, et al.
Arthritis Care Res (Hoboken)
. 2019 Jun;
72(9):1266-1274.
PMID: 31199593
Objective: To explore whether anxiety and depression are associated with clinical measures of disease for adolescent patients with juvenile idiopathic arthritis (JIA) and whether anxiety and depression are associated with...
7.
Cai R, Chaplin H, Livermore P, Lee M, Sen D, Wedderburn L, et al.
Pediatr Rheumatol Online J
. 2019 May;
17(1):23.
PMID: 31113443
Background: Young people (YP; 12-24 years old) with rheumatic diseases face many challenges associated with chronic illness in addition to the physiological and psychosocial changes of adolescence. Timely access to...
8.
Shoop-Worrall S, Hyrich K, Verstappen S, Sergeant J, Baildam E, Chieng A, et al.
Arthritis Care Res (Hoboken)
. 2019 Mar;
72(4):517-524.
PMID: 30875458
Objective: In pediatric research, investigators rely on proxy reports of outcome, such as the proxy-completed Childhood Health Assessment Questionnaire (C-HAQ), to assess function in juvenile idiopathic arthritis (JIA). As children...
9.
Webb K, Peckham H, Radziszewska A, Menon M, Oliveri P, Simpson F, et al.
Front Immunol
. 2019 Feb;
9:3167.
PMID: 30705679
Type 1 interferons (IFN) are an antiviral cytokine family, important in juvenile onset systemic lupus erythematosus (jSLE) which is more common in females, around puberty. We report that plasmacytoid dendritic...
10.
Hendry G, Shoop-Worrall S, Riskowski J, Andrews P, Baildam E, Chieng A, et al.
Rheumatol Adv Pract
. 2019 Jan;
2(2):rky039.
PMID: 30627693
Objective: The aim was to investigate the time course of lower limb disease activity and walking disability in children with JIA over a 5-year course. Methods: The Childhood Arthritis Prospective...